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Introduction
A
ddiction to illegal drugs has posed itself as 
a major global problem and has damaged 
many families and communities beyond repair. Iran 
is subject to a flood of opium due to its extensive 
borders  with  the  foremost  of  international  drug 
producers: Afghanistan and Pakistan. There are 2 
million drug addicts and 800 thousand recreational 
drug users in Iran, which amounts to 4% of the 
Iranian population (1).
The 1950s marked the appearance of injecting 
drug users (IDUs), and consequently the emergence 
* Correspondence:
Zohreh Azarkar, M.D.
Assistant Professor of Infectious Disease, Department of 
Infectious Disease, Birjand University Medical Sciences, 
Birjand, Iran.
Tel/Fax: +98 561 444 3000
E-mail: drz.azarkar@yahoo.com
Received:  18 Apr 2009                Revised:  25 Nov 2009
Accepted:  11 Dec 2009 
Hepat Mon 2010; 10 (1): 26-30
Background and Aims: Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) are 
common infections among prisoners. Addicted prisoners are at a higher risk than the normal population for contracting 
these diseases. Many studies have reported higher prevalence rates of HBV, HCV, and HIV in prisoners. Because of this 
problem, this study was conducted to evaluate the serologic prevalence of these three diseases in prisoners convicted of 
drug-related crimes.
Methods: A descriptive cross-sectional study was conducted on a random sample of prisoners with drug charges who 
were inmates in a prison in Birjand, Iran. Information was collected via questionnaire after obtaining prisoners’ informed 
consent and blood samples were tested for hepatitis B surface antigen (HBsAg), antibodies to HCV (anti-HCV), and anti-
bodies to HIV (anti-HIV). The results were analyzed by chi-square tests.
Results: In this study, 358 prisoners were selected. 80.2% of prisoners were male, and 19.8% were female. The average 
age was 34.7±12 years. 39.1% were addicted to drugs, 54.2% were smokers, and 19.3% had tattoos. 8.4% had had 
extramarital intercourse, and 16.8% had had a sexually transmitted disease (STD) in past. HBsAg, anti-HCV, and anti-
HIV prevalence in these samples were 6.1%, 8.1%, and 0%, respectively. The prevalence rate of HBV in the addicted 
prisoners was 4.3%, and the rate in non-addicted prisoners was 7.3% (P = 0.24). The prevalence of HCV in addicted pris-
oners was 15.7%, and the prevalence in non-addicted prisoners was 3.2%; this difference was significant (P < 0.001). 
Furthermore, a significant difference between the prevalence of HBV and extramarital intercourse was noted (P < 0.005). 
A significant difference between HCV and transfusion, history of STDs, addiction, and tattooing was noted.
Conclusions: The survey showed that HCV, HBV, and HIV prevalence rates in prisoners were 8.1%, 6.1%, 0%, respec-
tively. The prevalence rates of HCV and HBV in addicted prisoners were 15.7% and 4.3 %, respectively. Studies per-
formed in Iran and other countries have shown that the prevalence rates of HBV, HCV, and HIV in addicted prisoners were 
higher than the rates in non-addicted prisoners. These results indicate that HBV, HCV, and HIV are significant problems in 
prisons, and efforts to reduce the risk of these infections, such as education and vaccination, should be considered.
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of  new  problems,  particularly  infectious  diseases. 
Infection  is  the  most  prevalent  cause  of  death 
among drug addicts. Most IDUs share syringes and 
needles for injection. Most of them are friends or 
relatives or simply strangers given shared syringes in 
injection galleries. These galleries are secret places 
where instruments of injection are lent to IDUs. The 
IDUs obtain their drugs from these galleries as well. 
These places are especially risky for the transmission 
of infectious agents (2).
Nowadays, addiction, particularly injection, is the 
greatest  risk  factor  for  blood-borne  viral  diseases 
such  as  Hepatitis  B,  Hepatitis  C,  and  acquired 
immune-deficiency syndrome (AIDS) (3).
In  a  study  conducted  on  479  addict  prisoners 
in  Hamadan,  Iran  in  2002,  58.4%  were  non-IV 
drug abusers, and the frequencies of antibody to 
hepatitis  C  virus  (HCV  Ab),  hepatitis  B  surface 
antigen (HBsAg), and antibody to human immune 
deficiency virus (HIV Ab) were 7.35%,1.46%, and 
1.04%, respectively (4).
Epidemiologically,  addicts  (IDUs  in  particular) 
constitute the second-largest population of AIDS 
patients  after  homosexuals.  The  two  populations 
who  are  most  susceptible  to  HIV  infection  are 
prison inmates and individuals who share  injection 
instruments (5).
Hepatitides are another complication of injecting 
addictions. Parallel alcohol consumption in hepatitis 
patients has been found to accelerate the process of 
hepatic damage and its progression to cirrhosis. Viral 
hepatitides B, C, and D are transmissible through 
shared syringe needles (2, 6).
There  are  200  million  cases  of  hepatitis  C 
worldwide,  and  IDUs  constitute  42%  of  patients 
suffering from the disease, most of whom progress 
to chronic hepatitis. Injecting addictions play a greater 
role in transmission of HCV than does sexual activity 
(2). Indeed, it is believed that the most important and 
prevalent route of transmission for this disease is 
intravenous injection among drug abusers. Seventy-
eight percent of IDUs develop hepatitis C after 1 
year, 83% after 5 years, and 94% after 10 years or 
more (7, 8).
In another Iranian study, this one conducted on 
312 addicted male prisoners 2002, the prevalence of 
HCV infection was found to be 30.8%. The major 
risk factors in this sample were duration of addiction, 
duration  of  imprisonment,  length  of  alcohol 
consumption , having multiple sexual partners, route 
of drug use, and type of drug (9). 
There are 400 million cases of hepatitis B infection 
worldwide. Two million people die each year from 
complications of hepatitis B, most notably hepatic 
cirrhosis and hepatocellular carcinoma (10).
In a study conducted in Nahavand, Iran in 2004, 
a history of surgery and a history of incarceration 
were  the  most  common  risk  factors  for  HBV 
infection (11).
Sixty  percent  of  Iranian  prisoners  have  been 
condemned for drug-related crimes, and 15-20% of 
other crimes are also associated with addiction and 
drug trafficking.
In  short,  prison  inmates  are  at  high  risk  of 
contracting hepatitis B, hepatitis C, and HIV due 
to high frequency of drug abuse and unsafe sexual 
activities.  Different studies have suggested serologic 
evidence  of  HCV  infection  in  one  out  of  three 
prisoners (12-14). Despite these realities, inmates are 
not routinely screened for these infections. There is 
an annual screening for AIDS among prisoners in 
Iran, but little is known about hepatitis infections, 
especially hepatitis C (15). 
This  study  was  conducted  to  evaluate  the 
serologic prevalence of hepatitis B, hepatitis C, and 
HIV in prisoners convicted of drug-related crimes. 
These infections were compared among addict and 
non-addict inmates.
Materials and Methods
This analytical-descriptive study was conducted 
on 358 prisoners with drug-related convictions in 
Birjand,  Iran.  The  cases  were  selected  randomly 
from  the  list  of  prisoners’  codes.  Subsequently, 
anonymous questionnaires based on the confidential 
codes of the prison authorities, including prisoners’ 
demographic data and risk factors, were completed 
by  the  public  health  experts  through  interviews 
with prisoners. Then, 5 mL of blood were drawn 
from each prisoner to be screened for hepatitis B, 
hepatitis C, and HIV. The samples were evaluated 
at the Blood Transfusion Center by enzyme-linked 
immunosorbent assay (ELISA). The collected data 
were entered into SPSS software and analyzed with 
chi-square tests, fisher’s exact tests, and regression 
logistics at α = 0.05.
Results
This study included 358 prisoners with drug-related 
sentences. The average age was 34.7 ± 12 years. Two 
hundred eighty seven (80.2%) of cases were men and 
71 (19.8%) were women. One hundred forty (39.1%) 
were addicted to drugs, and the most frequent routes 
of  intake  were  inhalation  (62.9%)  and  multiple 
routes (8.5%) (Table 1). The most frequently used 
substance was opium (102 cases; 72.9%). Among all Hepatitis Monthly, Winter 2010; 10(1): 26-30
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The findings of this study indicated that 39.1% 
of  prisoners  convicted  of  drug-related  crimes 
were drug abusers themselves. Moreover, 6.1% of 
inmates were infected with hepatitis B, and 8.1% 
were infected with hepatitis C. The prevalence of 
HIV was zero in our study.
The prevalence of hepatitis C was considerably 
higher  in  addicts  than  in  non-addicts  (15.7% 
compared  to  3.2%).  Because  these  infections  are 
transmissible through infected needles and syringes 
shared by IDUs, it is expected that IDUs should 
have a higher prevalence of these infections than 
the general population, particularly in the case of 
hepatitis C. For instance, in a study conducted on 
IDU prisoners in Mashad, Iran in 2002, 60% were 
infected with hepatitis C, 3% with hepatitis B, and 
7% with HIV (16). In a study conducted on addict 
prisoners  in  Khazarabad,  Iran  in  2001,  tattooed 
inmates were shown to have at least 3.5 times higher 
risk of infection with hepatitis C. Moreover, 30.8% 
of the cases were found to have hepatitis C, 81.7% 
of which were IDUs (15).
Indeed, tattooing may be a major route of HCV 
transmission. Our study indicates that the prevalence 
of  hepatitis  C  is  significantly  related  to  STDs, 
tattooing, and extramarital intercourse.
In another study conducted on prisoners of Sistan 
and Baluchestan, Iran in 2001, 8.4% of prisoners were 
HBsAg positive and 9.1% had hepatitis C infection 
(17). In a study conducted on high-risk groups in 
Bushehr, Iran in 2000, the rates of HBV and HCV 
infection among IDU prisoners were reported to be 
16.7% and 52.4%, respectively (18).
A study conducted in Iran, among 5,317 prisoners 
from 2001 to 2005 indicated a significant association 
between HBV infection and drug abuse in two out 
of every seven cases (4).
Another study conducted on 479 addict prisoners 
in  Hamadan,  Iran,  the  frequencies  of  HCV  Ab, 
HBsAg and HIV Ab were 7.35%, 1.46%, and 1.04%, 
respectively. The relationship between being an IDU 
and  antibody  to  HCV  (anti-HCV)  positivity  was 
statistically significant (4).
Studies conducted in Iran have reported a greater 
prevalence  of  hepatitis  B,  hepatitis  C,  and  HIV 
infection compared to our study, most likely because 
those studies were limited to IDU prisoners. Other 
studies  around  the  world  have  indicated  a  higher 
prevalence of all three diseases in drug addicts than 
in the general population.
In a study conducted on IDUs in Ireland, the 
prevalence  rates  of  HIV,  HBV,  and  HCV  were 
reported to be 24.5%, 9%, and 3.4%, respectively (3), 
which is expected because that study used a larger 
sample and was limited to drug addicts.
In a study conducted in the Texas-Mexico border 
on 320 anti-HCV positive and 307 anti-HCV negative 
cases, definite and potential risk factors for hepatitis 
C  transmission  were  evaluated.  The  multivariable 
analysis indicated tattooing, drug abuse, and blood 
transfusion  as  independent  and  significant  risk 
factors for hepatitis C transmission (19).
In a study conducted on 433 inmates in a Bologna 
prison,  Italy,  infection  rates  of  HIV,  HBV,  and 
HCV were reported to be 12.5%, 8.1%, and 31.3%, 
respectively.  Drug  addiction  was  common  among 
the inmates, and 33.9% of them were IDUs (20).
A 5-year study in a tuberculosis clinic in Moscow 
reported addiction (76%), hepatitis B, and C (77%) 
as  key  pathological  agents  in  association  with 
tuberculosis and AIDS (21).
In our study, hepatitis C was significantly more 
prevalent in drug addicts than in non-addicts. 
In a nationally representative survey of 1,193 Irish 
prisoners, 21% had experienced their fist injection 
in prison, and 71% shared needles. The results of 
the study suggested that 40% of prisoners in the 
republic of Ireland used drugs (22).
Other studies in Brazil and Glasgow indicated 
that hepatitis C infection was related to the duration 
of addiction and imprisonment (23, 24). 
When a drug addict feels a desire for drugs, he or 
she will be willing to do almost anything to fulfill his 
or her desire. In prisons, where few people have access 
to instruments of drug consumption, it is quite likely 
that inmates will tend to perform risky actions such 
as sharing infected syringes and needles. Many people 
who did not inject previously might be tempted to take 
up the habit of injection due to the limited options in 
prisons and the method’s rapid effects. These facts 
underline the dangerous role of prisons in infecting 
prisoners with HIV and hepatitis.
Not  only  is  an  addict  prisoner  susceptible  to 
perilous diseases such as AIDS and hepatitis, but he 
also may function as a vehicle for transmission of 
causative agents.
A study evaluating the effects of interventions 
such as providing abundant needles for IDUs from 
1990 to 2001 reported a decrease in the prevalence 
rates  of  HIV  and  HCV  from  54%  to  13%  and 
from 80% to 63%, respectively (25), highlighting the 
importance that such interventions could have for 
our country.
Conclusions
The  findings  of  our  study  indicate  a  high 
prevalence  of  HBV  and  HCV  infections  in  drug 
addicted prisoners. Unhealthy and risky behaviors Hepatitis Monthly, Winter 2010; 10(1): 26-30
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such  as  tattooing,  extramarital  sexual  intercourse, 
and drug addiction were the most important factors 
related  to  infection.  Infected  prisoners  eventually 
return to their families and communities and can 
easily spread their infections through risky behaviors. 
Therefore, routine screening of addicts, especially in 
prisons, and training inmates about personal health 
and the necessity of using clean needles, becoming 
immunized  against  hepatitis  B,  and  treating  their 
addictions are suggested as pre-emptive measures.
Furthermore, informing individuals, particularly 
the younger generations, of the dangers associated 
with  drug  use,  even  moderate  use,  is  of  utmost 
importance.
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